ClinicalTrials.govpublic full text
GTB-3550 Tri-Specific Killer Engager (TriKE®) for High Risk Hematological Malignancies
high-risk myelodysplastic syndromes, acute myelogenous leukemia, systemic mastocytosis, mast cell leukemia, myelodysplastic syndromes (mds), acute myeloid leukemia (aml), interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 810075
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.